NVOS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NVOS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-22), Novo Integrated Sciences's current share price is $0.47735. Novo Integrated Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2024 was $4.05. Novo Integrated Sciences's Cyclically Adjusted PS Ratio for today is 0.12.
The historical rank and industry rank for Novo Integrated Sciences's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Novo Integrated Sciences's highest Cyclically Adjusted PS Ratio was 54.92. The lowest was 0.11. And the median was 6.30.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Novo Integrated Sciences's adjusted revenue per share data for the three months ended in Feb. 2024 was $0.180. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $4.05 for the trailing ten years ended in Feb. 2024.
The historical data trend for Novo Integrated Sciences's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novo Integrated Sciences Quarterly Data | ||||||||||||||||||||
May19 | Aug19 | Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Feb22 | May22 | Aug22 | Nov22 | Feb23 | May23 | Aug23 | Nov23 | Feb24 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | 0.28 | 0.30 | 0.33 | 0.29 | 0.16 |
For the Medical Care Facilities subindustry, Novo Integrated Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Novo Integrated Sciences's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Novo Integrated Sciences's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 0.47735 | / | 4.05 | |
= | 0.12 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novo Integrated Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2024 is calculated as:
For example, Novo Integrated Sciences's adjusted Revenue per Share data for the three months ended in Feb. 2024 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Feb. 2024 (Change) | * | Current CPI (Feb. 2024) |
= | 0.18 | / | 130.9299 | * | 130.9299 | |
= | 0.180 |
Current CPI (Feb. 2024) = 130.9299.
Novo Integrated Sciences Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201403 | 0.000 | 99.695 | 0.000 |
201406 | 0.000 | 100.560 | 0.000 |
201409 | 0.000 | 100.428 | 0.000 |
201412 | 0.000 | 99.070 | 0.000 |
201503 | 0.000 | 99.621 | 0.000 |
201506 | 0.000 | 100.684 | 0.000 |
201509 | 0.000 | 100.392 | 0.000 |
201512 | 0.000 | 99.792 | 0.000 |
201603 | 0.000 | 100.470 | 0.000 |
201606 | 0.000 | 101.688 | 0.000 |
201609 | 0.000 | 101.861 | 0.000 |
201612 | 0.000 | 101.863 | 0.000 |
201703 | 0.000 | 102.862 | 0.000 |
201708 | 1.104 | 103.587 | 1.395 |
201711 | 1.117 | 104.072 | 1.405 |
201802 | 1.041 | 105.052 | 1.297 |
201805 | 1.082 | 106.148 | 1.335 |
201808 | 1.046 | 106.383 | 1.287 |
201811 | 1.112 | 106.338 | 1.369 |
201902 | 1.027 | 106.649 | 1.261 |
201905 | 1.115 | 108.048 | 1.351 |
201908 | 1.082 | 108.245 | 1.309 |
201911 | 1.138 | 108.519 | 1.373 |
202002 | 1.053 | 109.139 | 1.263 |
202005 | 0.446 | 108.175 | 0.540 |
202008 | 0.789 | 109.662 | 0.942 |
202011 | 0.917 | 109.793 | 1.094 |
202102 | 0.874 | 110.968 | 1.031 |
202105 | 0.941 | 113.576 | 1.085 |
202108 | 1.015 | 115.421 | 1.151 |
202111 | 1.175 | 117.269 | 1.312 |
202202 | 0.998 | 119.703 | 1.092 |
202205 | 4.645 | 123.323 | 4.932 |
202208 | -2.624 | 124.958 | -2.749 |
202211 | 1.010 | 125.607 | 1.053 |
202302 | 0.322 | 126.928 | 0.332 |
202305 | 0.229 | 128.314 | 0.234 |
202308 | 0.221 | 129.538 | 0.223 |
202311 | 0.233 | 129.548 | 0.235 |
202402 | 0.180 | 130.930 | 0.180 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Novo Integrated Sciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Sarfaraz Ali | director | C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004 |
Robert Letterio Oliva | director | 115 BELFIELD RD, TORONTO A6 L0J 1C0 |
Sterling M. Jimenez | officer: Principal Financial Officer | C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004 |
Michael Ross Pope | director | 1045 PROGRESS CIRCLE, LAWRENCEVILLE, GEORGIA GA 30043 |
Alex Flesias | director | 41 LANDMARK COURT, UNIONVILLE A6 L3R 9N7 |
Michael Joseph Gaynor | director | 49 BALMORAL ST, KEMPTVILLE A6 K0G 1J0 |
Robert Mattacchione | director, 10 percent owner, officer: Chief Executive Officer | 79 SELVAPIANO CRES, WOODBRIDGE A6 L4H 0X1 |
Pierre Joseph Dalcourt | director, 10 percent owner | 35 BRYANT ST , BOX 2230, HEARST A6 P0L 1N0 |
Christopher Mehlin David | director, officer: President | 10425 SE 22ND ST., BELLEVUE WA 98004 |
Thomas Edward Bray | officer: Principal Financial Officer | C/O NOVO INTEGRATED SCIENCES, INC., 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004 |
Rebecca Aw Mcdonald | officer: Chief Accounting Officer | 1301 INTERNATIONAL SPEEDWAY BLVD., DELAND FL 32724 |
James Jr Teters | director | 1200 FLIGHTLINE BLVD, STE 5, DELAN FL 32724 |
Phyllis Rouse | officer: secretary | 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724 |
Jay Hilden | officer: President & CEO | 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724 |
Robert Adamo | director | 1200 FLIGHTLINE BOULEVARD, SUITE 5, DELAND FL 32724 |
From GuruFocus
By Business Wire • 10-24-2023
By Business Wire • 11-06-2023
By Business Wire Business Wire • 11-08-2022
By Business Wire • 08-31-2023
By Business Wire Business Wire • 03-24-2023
By Business Wire • 12-19-2023
By Business Wire Business Wire • 01-30-2023
By Business Wire Business Wire • 06-06-2023
By Business Wire Business Wire • 10-14-2022
By Business Wire • 09-28-2023